Chemoinformaics analysis of 15-Hydroxyimbricatolic acid
| Molecular Weight | 336.516 | nRot | 6 |
| Heavy Atom Molecular Weight | 300.228 | nRig | 13 |
| Exact Molecular Weight | 336.266 | nRing | 2 |
| Solubility: LogS | -4.476 | nHRing | 0 |
| Solubility: LogP | 4.193 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 61.4805 |
| nHD | 1 | BPOL | 38.7195 |
| QED | 0.563 |
| Synth | 4.158 |
| Natural Product Likeliness | 2.839 |
| NR-PPAR-gamma | 0.027 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.562 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.611 |
| MDCK | 0.0000217 |
| BBB | 0.429 |
| PPB | 0.783965 |
| VDSS | 0.6 |
| FU | 0.119283 |
| CYP1A2-inh | 0.277 |
| CYP1A2-sub | 0.374 |
| CYP2c19-inh | 0.246 |
| CYP2c19-sub | 0.872 |
| CYP2c9-inh | 0.356 |
| CYP2c9-sub | 0.199 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.196 |
| CYP3a4-inh | 0.909 |
| CYP3a4-sub | 0.252 |
| CL | 10.095 |
| T12 | 0.087 |
| hERG | 0.032 |
| Ames | 0.031 |
| ROA | 0.1 |
| SkinSen | 0.566 |
| Carcinogencity | 0.178 |
| EI | 0.147 |
| Respiratory | 0.946 |
| NR-Aromatase | 0.533 |
| Antiviral | Yes |
| Prediction | 0.589313 |